Insider · CIK 0001997505
Susan E Quaggin
director
Files at ABBV (AbbVie Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +59 | $261.59 | $15k | 918 | 10 d ago |
| Dec 31, 2025 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +68 | $228.49 | $16k | 707 | Jan 5, 2026 |
| Sep 30, 2025 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +67 | $231.54 | $16k | 634 | Oct 2, 2025 |
| Jun 30, 2025 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +81 | $185.62 | $15k | 562 | Jul 2, 2025 |
| May 9, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,203 | $0.00 | $0 | 2,525 | May 13, 2025 |
| Mar 31, 2025 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +71 | $209.52 | $15k | 476 | Apr 2, 2025 |
| Dec 31, 2024 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +84 | $177.70 | $15k | 401 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.